Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

(ROSG) logo

About (ROSG) Stock (NASDAQ:ROSG)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.44
50-Day Range
$0.43
$0.43
52-Week Range
$0.23
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

ROSG Stock News Headlines

War Tensions Are Making Gold Rise to Record Highs
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
Rosetta Genomics Ltd ROSGQ
See More Headlines

ROSG Stock Analysis - Frequently Asked Questions

(ROSG) (NASDAQ:ROSG) released its quarterly earnings data on Thursday, May, 19th. The medical research company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company earned $2.60 million during the quarter, compared to analyst estimates of $3.36 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Cos (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), Eyepoint Pharmaceuticals (EYPT) and (SCMP) (SCMP).

Company Calendar

Last Earnings
5/19/2016
Today
6/22/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ROSG) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners